Author Information
Alexandre Prehn Zavascki is a prominent figure in the field of Infectious Diseases, with a significant focus on the study and management of COVID-19. He is affiliated with multiple prestigious institutions in Porto Alegre, Brazil, including the Infectious Diseases Service at Hospital de Clínicas de Porto Alegre, the Department of Internal Medicine at the Medical School of Universidade Federal do Rio Grande do Sul, and the Infectious Diseases Service at Hospital Moinhos de Vento. His work primarily revolves around infectious disease surveillance, diagnostic accuracy, and therapeutic interventions.Research Contributions
Throughout his career, Alexandre Prehn Zavascki has made substantial contributions to the understanding of infectious diseases, particularly in relation to COVID-19. His research has addressed critical areas such as genomic surveillance of SARS-CoV-2 variants, diagnostic accuracy of rapid tests, and therapeutic strategies for COVID-19. Notably, he has focused on the early identification and impact of SARS-CoV-2 variants like P.1 (Gamma) and C.37 (Lambda) in Southern Brazil. His work has provided valuable insights into the epidemiology, diagnosis, and treatment of COVID-19, influencing both clinical practice and public health policies.Aliases
Throughout his academic career, Alexandre Prehn Zavascki has been referenced by various names, including Alexandre P. Zavascki, A. P. Zavascki, Alexandre Zavascki, and A P Zavascki. These aliases are commonly used in publications and citations within the scientific community.Publication and Citation Metrics
| Metric |
Value |
| Total Papers |
191 |
| Total Citations |
5253 |
| H-index |
38 |
